Royal Bank of Canada’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2K | Sell |
1,551
-5,217
| -77% | -$7.59K | ﹤0.01% | 6716 |
|
|
2025
Q4 | $7K | Sell |
6,768
-715,667
| -99% | -$983K | ﹤0.01% | 6589 |
|
|
2025
Q3 | $975K | Sell |
722,435
-52,039
| -7% | -$59.1K | ﹤0.01% | 4011 |
|
|
2025
Q2 | $732K | Buy |
774,474
+771,315
| +24,416% | +$500K | ﹤0.01% | 4170 |
|
|
2025
Q1 | $1K | Sell |
3,159
-6,752
| -68% | -$4.26K | ﹤0.01% | 6679 |
|
|
2024
Q4 | $7K | Sell |
9,911
-1,488
| -13% | -$1.79K | ﹤0.01% | 6453 |
|
|
2024
Q3 | $18K | Buy |
11,399
+561
| +5% | +$999 | ﹤0.01% | 6137 |
|
|
2024
Q2 | $18K | Buy |
10,838
+8,670
| +400% | +$15.6K | ﹤0.01% | 6112 |
|
|
2024
Q1 | $5K | Sell |
2,168
-26,917
| -93% | -$57.8K | ﹤0.01% | 6447 |
|
|
2023
Q4 | $44K | Buy |
29,085
+15,307
| +111% | +$18.2K | ﹤0.01% | 6050 |
|
|
2023
Q3 | $15K | Buy |
13,778
+5,871
| +74% | +$10.3K | ﹤0.01% | 6281 |
|
|
2023
Q2 | $18K | Buy |
7,907
+3,247
| +70% | +$8.62K | ﹤0.01% | 6267 |
|
|
2023
Q1 | $11K | Sell |
4,660
-7,960
| -63% | -$18.2K | ﹤0.01% | 6266 |
|
|
2022
Q4 | $24K | Buy |
12,620
+11,585
| +1,119% | +$24.7K | ﹤0.01% | 6233 |
|
|
2022
Q3 | $2K | Buy |
1,035
+115
| +13% | +$318 | ﹤0.01% | 7037 |
|
|
2022
Q2 | $2K | Sell |
920
-3,891
| -81% | -$7.42K | ﹤0.01% | 6966 |
|
|
2022
Q1 | $10K | Sell |
4,811
-8,975
| -65% | -$24.9K | ﹤0.01% | 6945 |
|
|
2021
Q4 | $54K | Buy |
13,786
+7,109
| +106% | +$34.5K | ﹤0.01% | 6336 |
|
|
2021
Q3 | $31K | Buy |
6,677
+1,492
| +29% | +$6.12K | ﹤0.01% | 6444 |
|
|
2021
Q2 | $23K | Buy |
5,185
+533
| +11% | +$2.57K | ﹤0.01% | 6496 |
|
|
2021
Q1 | $27K | Buy |
4,652
+3,440
| +284% | +$23.8K | ﹤0.01% | 6251 |
|
|
2020
Q4 | $4K | Sell |
1,212
-443
| -27% | -$845 | ﹤0.01% | 6731 |
|
|
2020
Q3 | $2K | Buy |
1,655
+363
| +28% | +$646 | ﹤0.01% | 6324 |
|
|
2020
Q2 | $3K | Sell |
1,292
-2,301
| -64% | -$4.51K | ﹤0.01% | 6187 |
|
|
2020
Q1 | $7K | Buy |
3,593
+2,998
| +504% | +$8.92K | ﹤0.01% | 5942 |
|
|
2019
Q4 | $3K | Sell |
595
-183
| -24% | -$704 | ﹤0.01% | 6491 |
|
|
2019
Q3 | $2K | Buy |
778
+39
| +5% | +$121 | ﹤0.01% | 6290 |
|
|
2019
Q2 | $5K | Sell |
739
-20
| -3% | -$120 | ﹤0.01% | 6310 |
|
|
2019
Q1 | $4K | Buy |
759
+450
| +146% | +$2.73K | ﹤0.01% | 6343 |
|
|
2018
Q4 | $2K | Sell |
309
-896
| -74% | -$7.26K | ﹤0.01% | 6449 |
|
|
2018
Q3 | $13K | Buy |
1,205
+735
| +156% | +$8.42K | ﹤0.01% | 5879 |
|
|
2018
Q2 | $6K | Sell |
470
-716
| -60% | -$7.32K | ﹤0.01% | 5984 |
|
|
2018
Q1 | $10K | Buy |
1,186
+526
| +80% | +$4.86K | ﹤0.01% | 5714 |
|
|
2017
Q4 | $7K | Sell |
660
-4,095
| -86% | -$42.5K | ﹤0.01% | 5982 |
|
|
2017
Q3 | $58K | Buy |
4,755
+4,398
| +1,232% | +$64.9K | ﹤0.01% | 5327 |
|
|
2017
Q2 | $6K | Sell |
357
-1,240
| -78% | -$19.2K | ﹤0.01% | 5982 |
|
|
2017
Q1 | $24K | Buy |
1,597
+118
| +8% | +$1.75K | ﹤0.01% | 5538 |
|
|
2016
Q4 | $20K | Sell |
1,479
-16,207
| -92% | -$260K | ﹤0.01% | 5764 |
|
|
2016
Q3 | $319K | Sell |
17,686
-7,488
| -30% | -$121K | ﹤0.01% | 4085 |
|
|
2016
Q2 | $362K | Sell |
25,174
-6,712
| -21% | -$91K | ﹤0.01% | 3964 |
|
|
2016
Q1 | $381K | Buy |
31,886
+31,101
| +3,962% | +$326K | ﹤0.01% | 3875 |
|
|
2015
Q4 | $11K | Sell |
785
-1,608
| -67% | -$19.8K | ﹤0.01% | 5934 |
|
|
2015
Q3 | $26K | Sell |
2,393
-854
| -26% | -$9.33K | ﹤0.01% | 5451 |
|
|
2015
Q2 | $26K | Buy |
3,247
+1,661
| +105% | +$12.2K | ﹤0.01% | 5569 |
|
|
2015
Q1 | $10K | Buy |
1,586
+435
| +38% | +$2.97K | ﹤0.01% | 5573 |
|
|
2014
Q4 | $7K | Buy |
1,151
+17
| +1% | +$137 | ﹤0.01% | 5714 |
|
|
2014
Q3 | $11K | Buy |
1,134
+333
| +42% | +$3.56K | ﹤0.01% | 5452 |
|
|
2014
Q2 | $9K | Buy |
801
+107
| +15% | +$1.15K | ﹤0.01% | 5437 |
|
|
2014
Q1 | $9K | Sell |
694
-505
| -42% | -$6.45K | ﹤0.01% | 5462 |
|
|
2013
Q4 | $15K | Sell |
1,199
-675
| -36% | -$10.7K | ﹤0.01% | 5353 |
|
|
2013
Q3 | $31K | Buy |
1,874
+1,781
| +1,915% | +$29.9K | ﹤0.01% | 5011 |
|
|
2013
Q2 | $1K | Buy |
+93
| New | +$1.41K | ﹤0.01% | 5726 |
|
Other funds holding LXRX
AG
SL
SC
VCM
Royal Bank of Canada's LXRX Position: Q1 2026 in Review
Royal Bank of Canada reduced its Lexicon Pharmaceuticals (LXRX) stake by 77% in Q1 2026, selling an estimated $7.59K and leaving 1,551 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #6716.
Royal Bank of Canada first reported a position in LXRX in Q2 2013 and has held it in 52 quarters since. The position peaked at $975K in Q3 2025. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.
- Royal Bank of Canada held 1,551 shares of Lexicon Pharmaceuticals worth $2K as of Q1 2026.
- Royal Bank of Canada sold 5,217 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $7.59K.
- Lexicon Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6716 holding.
- Royal Bank of Canada first reported a position in Lexicon Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Lexicon Pharmaceuticals position peaked at $975K in Q3 2025.
- 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.